Alissa Hyppolite

Alissa Hyppolite, serving as an associate at Bereskin & Parr LLP within the Life Sciences practice group, brings a fresh and dynamic approach to the intellectual property landscape. Her work is centered on evaluating the patentability of groundbreaking technologies, meticulously drafting and prosecuting patent applications, and offering strategic guidance for the effective management of patent portfolios, particularly in the realm of biotechnology.

Holding a law degree with a specialization in law and technology from the University of Ottawa, coupled with a degree in Biomedical Science from the same institution, Alissa's academic background perfectly marries the worlds of science and law. Her research experience in molecular biology enriches her understanding of the complexities inherent in life sciences, allowing her to provide informed and nuanced advice to her clients.

Alissa's prior roles include a legal intern and student policy analyst at the Canadian Intellectual Property Office (CIPO), where she honed her skills in trademark-related areas. Her tenure as a legal intern with Global Affairs Canada further broadened her perspective, particularly on how emerging technologies like 3D printing impact intellectual property rights.

Outside the office, Alissa's life is filled with travel, literature, art, and quality moments with loved ones and her Corgi, Cannoli, embodying Albert Einstein's belief that "Creativity is intelligence having fun."

Admitted to the Ontario Bar in 2020 and on track to become a Registered Canadian Patent Agent by 2024, Alissa's credentials are impressive. Her membership in the Intellectual Property Institute of Canada, Law Society of Ontario, and Women in Bio, underscores her active engagement in the IP community.

Alissa Hyppolite's expertise spans across cannabis, IP management and strategic counseling, life sciences, medical technology, and patents. Her blend of scientific insight and legal acumen makes her a valuable asset to those navigating the intricate domain of intellectual property in the life sciences sector.